Literature DB >> 10431168

Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections.

B Tümmler1, C Kiewitz.   

Abstract

Cystic fibrosis is a severe monogenic disorder of ion transport in exocrine glands. The basic defect predisposes to chronic bacterial airway infections with Staphylococcus aureus, Haemophilus influenzae, Pseudomonas aeruginosa and Burkholderia cepacia. The Pseudomonas infections in cystic fibrosis are a paradigm of how versatile environmental bacteria can conquer, adapt and persist in an atypical habitat and successfully evade defence mechanisms and chemotherapy in a susceptible host. Regular chemotherapy with aerosol and systemic antipseudomonal drugs has improved the course and prognosis of the disease, and research for effective vaccines is on the way.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10431168     DOI: 10.1016/s1357-4310(99)01506-3

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  30 in total

1.  High-frequency flp recombinase-mediated inversions of the oriC-containing region of the Pseudomonas aeruginosa genome.

Authors:  N Barekzi; K Beinlich; T T Hoang; X Q Pham; R Karkhoff-Schweizer; H P Schweizer
Journal:  J Bacteriol       Date:  2000-12       Impact factor: 3.490

2.  Bacteriocin-mediated competition in cystic fibrosis lung infections.

Authors:  Melanie Ghoul; Stuart A West; Helle Krogh Johansen; Søren Molin; Odile B Harrison; Martin C J Maiden; Lars Jelsbak; John B Bruce; Ashleigh S Griffin
Journal:  Proc Biol Sci       Date:  2015-09-07       Impact factor: 5.349

3.  Dry powder aerosol containing muco-inert particles for excipient enhanced growth pulmonary drug delivery.

Authors:  Guihong Chai; Amr Hassan; Tuo Meng; Lihua Lou; Jonathan Ma; Russell Simmers; Lei Zhou; Bruce K Rubin; Qi Tony Zhou; P Worth Longest; Michael Hindle; Qingguo Xu
Journal:  Nanomedicine       Date:  2020-07-03       Impact factor: 5.307

4.  Breaking the Vicious Cycle of Antibiotic Killing and Regrowth of Biofilm-Residing Pseudomonas aeruginosa.

Authors:  Mathias Müsken; Vinay Pawar; Timo Schwebs; Heike Bähre; Sebastian Felgner; Siegfried Weiss; Susanne Häussler
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

5.  Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response.

Authors:  Susanne J Bauman; Meta J Kuehn
Journal:  Microbes Infect       Date:  2006-06-05       Impact factor: 2.700

6.  Expression of the psl operon in Pseudomonas aeruginosa PAO1 biofilms: PslA performs an essential function in biofilm formation.

Authors:  Jörg Overhage; Mirle Schemionek; Jeremy S Webb; Bernd H A Rehm
Journal:  Appl Environ Microbiol       Date:  2005-08       Impact factor: 4.792

7.  Transcriptome Profiling of Antimicrobial Resistance in Pseudomonas aeruginosa.

Authors:  Ariane Khaledi; Monika Schniederjans; Sarah Pohl; Roman Rainer; Ulrich Bodenhofer; Boyang Xia; Frank Klawonn; Sebastian Bruchmann; Matthias Preusse; Denitsa Eckweiler; Andreas Dötsch; Susanne Häussler
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

8.  PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients.

Authors:  A McDowell; E Mahenthiralingam; J E Moore; K E Dunbar; A K Webb; M E Dodd; S L Martin; B C Millar; C J Scott; M Crowe; J S Elborn
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

9.  Stress-induced outer membrane vesicle production by Pseudomonas aeruginosa.

Authors:  Ian A Macdonald; Meta J Kuehn
Journal:  J Bacteriol       Date:  2013-04-26       Impact factor: 3.490

10.  Negative control of quorum sensing by RpoN (sigma54) in Pseudomonas aeruginosa PAO1.

Authors:  Karin Heurlier; Valerie Dénervaud; Gabriella Pessi; Cornelia Reimmann; Dieter Haas
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.